Escitalopram Oxalate
- Product NDC
- 65162-705
- 11-digit product format
- 651620705
- Labeler code
- 65162
- Product ID
- 65162-705_d29f980a-e696-4020-8bf9-8f81016c0699
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Escitalopram
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA202227
- Marketing category
- ANDA
- Marketing start
- 2011-09-03
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 5 mg/5mL
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Escitalopram Oxalate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ESCITALOPRAM OXALATE | 5 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5U85DBW7LO |
| Rxcui | 351285 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65162-705-88 | Escitalopram Oxalate | 240 mL in 1 BOTTLE | SOLUTION | 240 | | 38 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ESCITALOPRAM OXALATE | ACTIVE INGREDIENT | 5U85DBW7LO | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| ESCITALOPRAM | ACTIVE MOIETY | 4O4S742ANY | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| MALIC ACID | INACTIVE INGREDIENT | 817L1N4CKP | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| PEPPERMINT | INACTIVE INGREDIENT | V95R5KMY2B | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-705 | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS LLC] | 38 | Current NDC, Legacy NDC, 1 package rows | 20250502_09894a38-4e3a-475d-96cd-c6c8ed87869a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-705-88 | 65162070588 | 240 mL in 1 BOTTLE (65162-705-88) | 240 ml | 2011-09-03 | 0000-00-00 | No | No | Current |